Study of LM-102 in Subjects in Advanced Tumors

Clinical trial NCT04735796 · TERMINATED

Trial details

NCT number: NCT04735796
Sponsor: LaNova Medicines Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-05-27
Primary completion: 2022-05-19
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.